Gargoyle Investment Advisor’s Myriad Genetics MYGN Stock Holding History

Gargoyle Investment Advisor’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-8,405	Closed	-$248K	–	146
2018 Q1	$248K	Hold	8,405	–	–	0.1%	150
2017 Q4	$289K	Hold	8,405	–	–	0.12%	150
2017 Q3	$304K	Buy	+8,405	New	+$240K	0.11%	149
2016 Q4	–	Sell	-16,200	Closed	-$333K	–	198
2016 Q3	$333K	Sell	16,200 -4,500	-22%	-$114K	0.13%	168
2016 Q2	$634K	Sell	20,700 -27,367	-57%	-$951K	0.24%	128
2016 Q1	$1.8M	Sell	48,067 -28,185	-37%	-$1.06M	0.61%	82
2015 Q4	$3.29M	Buy	76,252 +313	+0.4%	+$13.2K	1.34%	9
2015 Q3	$2.85M	Hold	75,939	–	–	1.17%	22
2015 Q2	$2.58M	Hold	75,939	–	–	0.98%	36
2015 Q1	$2.69M	Hold	75,939	–	–	1.01%	36
2014 Q4	$2.59M	Sell	75,939 -14,200	-16%	-$504K	0.95%	54
2014 Q3	$3.48M	Buy	90,139 +2,100	+2%	+$78.4K	1.32%	25
2014 Q2	$3.33M	Buy	88,039 +14,034	+19%	+$522K	1.25%	24
2014 Q1	$2.53M	Buy	74,005 +14,876	+25%	+$461K	1.13%	49
2013 Q4	$1.24M	Hold	59,129	–	–	0.59%	58
2013 Q3	$1.28M	Hold	59,129	–	–	0.79%	55
2013 Q2	$1.59M	Buy	+59,129	New	+$1.71M	0.8%	61

Other funds holding MYGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Gargoyle Investment Advisor's MYGN Position: Q2 2018 in Review

Gargoyle Investment Advisor sold out of Myriad Genetics (MYGN) in Q2 2018, closing a stake of 8,405 shares — an estimated $248K sold.

Gargoyle Investment Advisor first reported a position in MYGN in Q2 2013 and held it in 17 quarters. The position peaked at $3.48M in Q3 2014. 258 funds tracked by Wall St. Rank hold MYGN as of Q2 2018.

Gargoyle Investment Advisor reported no remaining Myriad Genetics position as of Q2 2018 after selling out during the quarter.
Gargoyle Investment Advisor sold 8,405 Myriad Genetics shares in Q2 2018, an estimated $248K.
Gargoyle Investment Advisor first reported a position in Myriad Genetics in Q2 2013 and held it in 17 quarters.
Gargoyle Investment Advisor's Myriad Genetics position peaked at $3.48M in Q3 2014.
258 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2018.

Based on Gargoyle Investment Advisor's 13F filing for Q2 2018, filed 14 Aug 2018.